Healthcare - Industry Center - Yahoo Finance
- BMYMarket Realist•10 minutes ago
Given the strong performance of Opdivo, the Oncology segment has emerged as the largest revenue contributor for Bristol-Myers Squibb (BMY) during the last few quarters.
- GSKMarket Realist•11 minutes ago
The Novartis acquisition has improved sales for GSK's Vaccines business, mainly driven by the sales of meningitis vaccines Bexsero in Europe and Menveo in the US and Europe.
- GSKTheStreet.com•23 minutes ago
GlaxoSmithKline posted stronger-than-expected first quarter earnings and kept its full year profit and revenue figures in place as it awaits potential rivals to is Advair respiratory treatment.line